Merck (MRK) Restructuring Costs (2016 - 2025)
Historic Restructuring Costs for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $47.0 million.
- Merck's Restructuring Costs fell 1607.14% to $47.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $727.0 million, marking a year-over-year increase of 4143.97%. This contributed to the annual value of $309.0 million for FY2024, which is 4841.4% down from last year.
- According to the latest figures from Q3 2025, Merck's Restructuring Costs is $47.0 million, which was down 1607.14% from $560.0 million recorded in Q2 2025.
- Over the past 5 years, Merck's Restructuring Costs peaked at $560.0 million during Q2 2025, and registered a low of $47.0 million during Q3 2025.
- Over the past 5 years, Merck's median Restructuring Costs value was $94.0 million (recorded in 2022), while the average stood at $135.9 million.
- Its Restructuring Costs has fluctuated over the past 5 years, first crashed by 8215.49% in 2022, then skyrocketed by 60000.0% in 2025.
- Over the past 5 years, Merck's Restructuring Costs (Quarter) stood at $174.0 million in 2021, then tumbled by 71.84% to $49.0 million in 2022, then soared by 420.41% to $255.0 million in 2023, then tumbled by 80.0% to $51.0 million in 2024, then fell by 7.84% to $47.0 million in 2025.
- Its Restructuring Costs stands at $47.0 million for Q3 2025, versus $560.0 million for Q2 2025 and $69.0 million for Q1 2025.